Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Cognitive impairment (CI) is common, with diverse underlying causes, symptoms, and imaging features. It often leads to disability and loss of independence. Early diagnosis and assessment of CI are crucial for the prognosis improvement. Conventional diagnostic methods for CI are hindered by subjectivity and imprecision. Radiomics, a sophisticated and objective methodology, has been increasingly utilized in CI in recent times. This article describes the methodology of radiomics and reviews the application of radiomics in the prediction and evaluation of cognitive impairment related to neurological diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), cerebral small vessel disease (CSVD), and stroke. It can provide imaging markers for the early diagnosis and risk stratification of cognitive impairment.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.